Skip to content

Clinical trials

Completed Phase 2 Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Phase: Phase 2 Status: Completed Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20052
20061
20082
20091
20102
20111
20121
20132
20142
20163
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione IRCCS Policlinico San Matteo di Pavia2
Attralus, Inc.1
Boston Medical Center1
Boston University1
Columbia University1
FDA Office of Orphan Products Development1
Florian Michel1
Herbert Irving Comprehensive Cancer Center1
Insel Gruppe AG, University Hospital Bern1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis24
Immunoglobulin Light-chain Amyloidosis8
Alzheimer Disease4
Multiple Myeloma4
Hematologic Neoplasms2
Paraproteinemias2
Amyloidosis, Familial1
Anemia1
Arthritis1
Bone Diseases, Metabolic1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.